Response of a metastatic breast carcinoma with a previously uncharacterized ERBB2 G776V mutation to human epidermal growth factor receptor 2-targeted therapy

Yakov Chudnovsky; Runjun D. Kumar; Alexa B. Schrock; Caitlin Connelly; Kyle Gowen; Garrett M. Frampton; Rachel L. Erlich; Philip J. Stephens; Vincent A. Miller; Jeffrey S. Ross; Siraj M. Ali; Ron Bose

doi:10.1200/PO.16.00037

Response of a metastatic breast carcinoma with a previously uncharacterized ERBB2 G776V mutation to human epidermal growth factor receptor 2-targeted therapy

Yakov Chudnovsky, Runjun D. Kumar, Alexa B. Schrock, Caitlin Connelly, Kyle Gowen, Garrett M. Frampton, Rachel L. Erlich, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali, Ron Bose

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1-9
Number of pages	9
Journal	JCO Precision Oncology
Volume	2017
Issue number	1
DOIs	https://doi.org/10.1200/PO.16.00037
State	Published - Jan 1 2017

Access to Document

10.1200/PO.16.00037

Link to publication in Scopus

Cite this

Chudnovsky, Y., Kumar, R. D., Schrock, A. B., Connelly, C., Gowen, K., Frampton, G. M., Erlich, R. L., Stephens, P. J., Miller, V. A., Ross, J. S., Ali, S. M., & Bose, R. (2017). Response of a metastatic breast carcinoma with a previously uncharacterized ERBB2 G776V mutation to human epidermal growth factor receptor 2-targeted therapy. JCO Precision Oncology, 2017(1), 1-9. https://doi.org/10.1200/PO.16.00037

Chudnovsky, Yakov ; Kumar, Runjun D. ; Schrock, Alexa B. ; Connelly, Caitlin ; Gowen, Kyle ; Frampton, Garrett M. ; Erlich, Rachel L. ; Stephens, Philip J. ; Miller, Vincent A. ; Ross, Jeffrey S. ; Ali, Siraj M. ; Bose, Ron. / Response of a metastatic breast carcinoma with a previously uncharacterized ERBB2 G776V mutation to human epidermal growth factor receptor 2-targeted therapy. In: JCO Precision Oncology. 2017 ; Vol. 2017, No. 1. pp. 1-9.

@article{b06ff3f1d6354f28a02302f40f55fd1b,

title = "Response of a metastatic breast carcinoma with a previously uncharacterized ERBB2 G776V mutation to human epidermal growth factor receptor 2-targeted therapy",

author = "Yakov Chudnovsky and Kumar, {Runjun D.} and Schrock, {Alexa B.} and Caitlin Connelly and Kyle Gowen and Frampton, {Garrett M.} and Erlich, {Rachel L.} and Stephens, {Philip J.} and Miller, {Vincent A.} and Ross, {Jeffrey S.} and Ali, {Siraj M.} and Ron Bose",

year = "2017",

month = jan,

day = "1",

doi = "10.1200/PO.16.00037",

language = "English",

volume = "2017",

pages = "1--9",

journal = "JCO Precision Oncology",

issn = "2473-4284",

number = "1",

}

Chudnovsky, Y, Kumar, RD, Schrock, AB, Connelly, C, Gowen, K, Frampton, GM, Erlich, RL, Stephens, PJ, Miller, VA, Ross, JS, Ali, SM & Bose, R 2017, 'Response of a metastatic breast carcinoma with a previously uncharacterized ERBB2 G776V mutation to human epidermal growth factor receptor 2-targeted therapy', JCO Precision Oncology, vol. 2017, no. 1, pp. 1-9. https://doi.org/10.1200/PO.16.00037

Response of a metastatic breast carcinoma with a previously uncharacterized ERBB2 G776V mutation to human epidermal growth factor receptor 2-targeted therapy. / Chudnovsky, Yakov; Kumar, Runjun D.; Schrock, Alexa B.; Connelly, Caitlin; Gowen, Kyle; Frampton, Garrett M.; Erlich, Rachel L.; Stephens, Philip J.; Miller, Vincent A.; Ross, Jeffrey S.; Ali, Siraj M.; Bose, Ron.

In: JCO Precision Oncology, Vol. 2017, No. 1, 01.01.2017, p. 1-9.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Response of a metastatic breast carcinoma with a previously uncharacterized ERBB2 G776V mutation to human epidermal growth factor receptor 2-targeted therapy

AU - Chudnovsky, Yakov

AU - Kumar, Runjun D.

AU - Schrock, Alexa B.

AU - Connelly, Caitlin

AU - Gowen, Kyle

AU - Frampton, Garrett M.

AU - Erlich, Rachel L.

AU - Stephens, Philip J.

AU - Miller, Vincent A.

AU - Ross, Jeffrey S.

AU - Ali, Siraj M.

AU - Bose, Ron

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85077489988&partnerID=8YFLogxK

U2 - 10.1200/PO.16.00037

DO - 10.1200/PO.16.00037

M3 - Article

AN - SCOPUS:85077489988

VL - 2017

SP - 1

EP - 9

JO - JCO Precision Oncology

JF - JCO Precision Oncology

SN - 2473-4284

IS - 1

ER -